This announcement is a separate document:
加科思-B:自願公告加科思在2024年第五屆RAS倡議研討會上展示SHP2抑制劑JAB-3312與KRAS G12C抑制劑戈來雷塞聯用臨床前數據
JACOBIO-B: VOLUNTARY ANNOUNCEMENTJACOBIO PRESENTED THE PRE-CLINICAL DATA OF SHP2 INHIBITORJAB-3312 IN COMBINATION WITH KRAS G12C INHIBITOR GLECIRASIBAT THE FIFTH RAS INITIATIVE SYMPOSIUM 2024
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.